Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Death & Disease|April 2, 2019
Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathwayYanbin Kuang, Wenzheng Guo, Jing Ling, et al.
Cancer Research|December 19, 2019
IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in LungBo Jing, Tong Wang, Beibei Sun, et al.
Oncogene|February 16, 2020
PTGES/PGE<sub>2</sub> signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse modelTong Wang, Bo Jing, Dongliang Xu, et al.
Neoplasia (New York, N.Y.)|May 10, 2019
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA DamageKaimi Li, Wenzheng Guo, Zhanming Li, et al.
Journal of Thoracic Disease|October 29, 2025
Immune-related cardiotoxicities predict immune checkpoint inhibitors treatment for advanced non-small cell lung cancer: a retrospective multi-center studyHengxing Sun, Yini Huang, Hongxia Duan, et al.
BMC Cancer|June 11, 2024
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage studyBo Zhang, Hongyu Liu, Chunlei Shi, et al.
Cancer Research|November 24, 2020
Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc<sup>-</sup> for Glutathione Synthesis in Lung CancerWenzheng Guo, Kaimi Li, Beibei Sun, et al.
JCI Insight|November 22, 2022
NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasiaHongyong Song, Xiaofeng Ye, Yueling Liao, et al.
Cancer Research|January 20, 2022
Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung AdenocarcinomaHuijing Yin, Bo Jing, Dongliang Xu, et al.
Lung Cancer (Amsterdam, Netherlands)|May 6, 2026
SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapyPanpan Zhang, Yanbin Kuang, Bo Jia, et al.
Pageof 3